{"id":190889,"date":"2025-09-19T00:00:00","date_gmt":"2025-09-19T00:00:00","guid":{"rendered":"https:\/\/medgoo.com\/index.php\/2025\/09\/19\/hormone-replacement-therapy-patches-safer-than-oral-delivery-for-women-with-diabetes\/"},"modified":"2025-09-23T16:10:26","modified_gmt":"2025-09-23T16:10:26","slug":"hormone-replacement-therapy-patches-safer-than-oral-delivery-for-women-with-diabetes","status":"publish","type":"post","link":"https:\/\/medgoo.com\/index.php\/2025\/09\/19\/hormone-replacement-therapy-patches-safer-than-oral-delivery-for-women-with-diabetes\/","title":{"rendered":"Hormone Replacement Therapy Patches Safer Than Oral Delivery for Women With Diabetes"},"content":{"rendered":"<h3>\n<p>Oral therapy tied to increased cardiovascular risk but not for estrogen-sensitive cancers<\/p>\n<\/h3>\n<p><b>By Lori Solomon HealthDay Reporter<\/b><br \/>\n<b><\/b><\/p>\n<p>FRIDAY, Sept. 19, 2025 (HealthDay News) &#8212; Hormone replacement therapy (HRT) patches carry lower cardiovascular risk than oral HRT among women with type 2 diabetes, according to a study presented at the annual meeting of the European Association for the Study of Diabetes, held from Sept. 15 to 19 in Vienna.<\/p>\n<p>Matthew Anson, from University of Liverpool in the United Kingdom, and colleagues used TriNetX electronic health record data to understand cardiovascular risk and gynecological- and estrogen-related cancers among women with type 2 diabetes using and not using HRT in midlife. The analysis included data from three cohorts composed of 24,986 patients.<\/p>\n<p>The researchers found that in cohort 1, compared with HRT users without diabetes, transdermal HRT in women with diabetes was associated with a greater risk for deep vein thrombosis (hazard ratio [HR], 1.90; P = 0.002), ischemic heart disease (HR, 1.77; P &lt; 0.001), and cerebral infarction (HR, 1.89; P &lt; 0.001). There were no differences in rates of pulmonary embolism and breast, ovarian, or endometrial carcinoma. In cohort 2, among individuals with diabetes, use of transdermal HRT was associated with only a reduced risk for ischemic heart disease (HR, 0.75; P &lt; 0.001) compared with nonusers. In cohort , among individuals with diabetes, use of oral versus transdermal HRT was associated with an increased risk for ischemic heart disease (HR, 1.21; P = 0.004) and pulmonary embolism (HR, 2.01; P &lt; 0.001), but with no differences in risk for the other outcomes.<\/p>\n<p>\u201cOur study suggests that up to five years of regulator-approved doses of transdermal HRT appears safe in a large cohort of women in midlife with type 2 diabetes,\u201d Anson said in a statement. \u201cHowever, given increased risks with oral HRT, we propose that women with type 2 diabetes should not be prescribed oral estrogen therapy.\u201d<\/p>\n<p><a href=\"https:\/\/drive.google.com\/file\/d\/1Pt90jDBkBaUnNeKPY73w8Z7U2xYLRSyo\/view\">Abstract<\/a><\/p>\n<p><a href=\"https:\/\/www.easd.org\/annual-meeting\/easd-2025.html\">More Information<\/a><\/p>\n<p><i><\/i><br \/>\n<i>Copyright &#169; 2025 <a href=\"https:\/\/consumer.healthday.com\/\" target=\"_new\">HealthDay<\/a>. All rights reserved.<\/i><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Oral therapy tied to increased cardiovascular risk but not for estrogen-sensitive cancers<\/p>\n","protected":false},"author":6,"featured_media":191782,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[6],"tags":[11],"class_list":["post-190889","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news","tag-news"],"_links":{"self":[{"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/posts\/190889","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/comments?post=190889"}],"version-history":[{"count":1,"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/posts\/190889\/revisions"}],"predecessor-version":[{"id":191407,"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/posts\/190889\/revisions\/191407"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/media\/191782"}],"wp:attachment":[{"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/media?parent=190889"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/categories?post=190889"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/tags?post=190889"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}